2025-05-02 20:44:24
Latest Post
Railtel Corporation of India Ltd Q4 FY2025 net profit surges to Rs. 113.45 crores
Jaiprakash Power Ventures Ltd Q4 FY25 consolidated net profit at Rs. 155.67 crores
Nuvoco Vistas Corporation Ltd Q4 FY2025 consolidated PAT soars to Rs. 165.54 crores
5paisa Capital Ltd consolidated Q4FY25 profit slides QoQ to Rs. 10.06 crores
Home First Finance Company India Ltd Q4 FY2025 PAT up at Rs. 104.69 crores
Stock Report
J B Chemicals & Pharmaceuticals Ltd Q2FY21 consolidated net profit slides to Rs. 73.82 crore
Posted On : 2020-11-10 23:49:45( TIMEZONE : IST )
J.B.CHEMICALS & PHARMACEUTICALS LTD. has reported financial results for the period ended September 30, 2020.
Financial Results (Q2 FY20-21) - QoQ Comparison
The company has reported total income of Rs.451.95 crores during the period ended September 30, 2020 as compared to Rs.544.97 crores during the period ended June 30, 2020.
The company has posted net profit / (loss) of Rs.73.82 crores for the period ended September 30, 2020 as against net profit / (loss) of Rs.119.42 crores for the period ended June 30, 2020.
The company has reported EPS of Rs.9.55 for the period ended September 30, 2020 as compared to Rs.15.45 for the period ended June 30, 2020.
| Financials | Q2 FY20-21 | Q1 FY20-21 | % Change |
| Total Income | ₹ 451.95 crs | ₹ 544.97 crs |  -17.07% |
| Net Profit | ₹ 73.82 crs | ₹ 119.42 crs | -38.18% |
| EPS | ₹ 9.55 | ₹ 15.45 | -38.19% |
Financial Results (Q2 FY20-21) - YoY Comparison
The company has reported total income of Rs.451.95 crores during the period ended September 30, 2020 as compared to Rs.474.92 crores during the period ended September 30, 2019.
The company has posted net profit / (loss) of Rs.73.82 crores for the period ended September 30, 2020 as against net profit / (loss) of Rs.93.62 crores for the period ended September 30, 2019.
The company has reported EPS of Rs.9.55 for the period ended September 30, 2020 as compared to Rs.11.67 for the period ended September 30, 2019.
| Financials | Q2 FY20-21 | Q2 FY19-20 | % Change |
| Total Income | ₹ 451.95 crs | ₹ 474.92 crs | -4.84% |
| Net Profit | ₹ 73.82 crs | ₹ 93.62 crs | -21.15% |
| EPS | ₹ 9.55 | ₹ 11.67 | -18.17% |
Financial Results (6 months ended FY 20-21) - YoY Comparison
The company has reported total income of Rs.996.93 crores during the 6 months period ended September 30, 2020 as compared to Rs.933.64 crores during the 6 months period ended September 30, 2019.
The company has posted net profit / (loss) of Rs.193.24 crores for the 6 months period ended September 30, 2020 as against net profit / (loss) of Rs.155.63 crores for the 6 months period ended September 30, 2019.
The company has reported EPS of Rs.25.01 for the 6 months period ended September 30, 2020 as compared to Rs.19.40 for the 6 months period ended September 30, 2019.
| Financials | Half-Year Ended FY20-21 | Half-Year Ended FY19-20 | % Change |
| Total Income | ₹ 996.93 crs | ₹ 933.64 crs |  6.78% |
| Net Profit | ₹ 193.24 crs | ₹ 155.63 crs | 24.17% |
| EPS | ₹ 25.01 | ₹19.40 | 28.92% |
Shares of J.B.CHEMICALS & PHARMACEUTICALS LTD. was last trading in BSE at Rs.968 as compared to the previous close of Rs. 1005.2. The total number of shares traded during the day was 17426 in over 3221 trades.
The stock hit an intraday high of Rs. 1013.9 and intraday low of 965. The net turnover during the day was Rs. 17053114.
